8:00 am - 9:40 am

SESSION FIVE

Chairs: F Casanueva (Santiago Compostela, Spain),

R Gaillard (Lausanne, Switzerland)

Non-functioning / TSH-secreting tumors

Genetic syndromes of T3 resistance

P Beck-Peccoz (Rozzano, Italy)

Experimental models of glycoprotein tumors

P Mellon (La Jolla, CA, USA)

Evaluation of the patient with a non-functioning pituitary mass

ML Vance (Charlottesville, VA, USA)

Recurrence: radiotherapy?

NJL Gittoes (Birmingham, UK)

9:40 am - 10:40 am

Poster viewing and coffee break

10:40 am - 12:20 pm

SESSION SIX

Chairs: C Wang (Torrance, CA, USA),

M Hartman (Indianapolis, IN, USA)

Replacement therapy: Diagnosis & treatment

Thyroid

JA Franklyn (Edgbaston, UK)

Cortisol

GP Chrousos (Bethesda, MD, USA)

Sex steroids

A Klibanski (Boston, MA, USA)

Growth hormone

S Shalet (Manchester, UK)

12:20 pm - 1:50 pm

Lunch seminars

1:50 pm - 4:10 pm

SESSION SEVEN

Chairs: C Strassburger (Munich, Germany),

M Sheppard (Birmingham, UK)

Novel pituitary ligands

Somatastatin - dopamine chimeras

M Culler (Milford, MA, USA)

SOM 230

C Bruns (Basel, Switzerland)

Radiolabled somatostatin analogs

W de Herder (Rotterdam, The Netherlands)

Ghrelin analogs

E Ghigo (Turin, Italy)

GH receptor antagonists

J Kopchick (Athens, Greece)

Mutant receptor rescuing ligands for the GnRH receptor: A new therapeutic approach based on receptor folding

PM Conn (Beaverton, OR, USA)

PPAR-gamma ligands

A Heaney (Los Angeles, CA, USA)

4:10 pm - 4:40 pm

Coffee break

4:40 pm - 6:10 pm

SESSION EIGHT

Chairs: M Thorner (Charlottesville, VA, USA),

BA Bengtsson (Gothenberg, Sweden)

Hot topics: presentations on exciting late-breaking developments

Selected from abstracts submitted to the meeting

6:10 pm - 6:15 pm

Closing remarks

7:30 pm

New York City Gala Dinner

at the Waldorf=Astoria